Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 223 followers
Latest posts
Last updated about 3 hours ago
STAT+: At JPM, doctors’ darling OpenEvidence says it’s pursuing ‘medical super-intelligence’
about 3 hours ago
OpenEvidence has rapidly become a household name among physicians with a chatbot...
STAT+: On Day 1 of JPM, no blockbuster headlines, but biotech newsmakers still move markets
about 4 hours ago
This is the online version of The Readout, STAT’s flagship biotech newsletter...
STAT+: With a grin — and tight lips — Revolution Medicines’ CEO faces questions about acquisition
about 4 hours ago
SAN FRANCISCO — Investors attending the J.P. Morgan Healthcare Conference packed themselves...
STAT+: Trump administration indicates it will drop appeal of a court order blocking a 340B pilot program
about 5 hours ago
The Trump administration has signaled plans to drop its appeal of a...
STAT+: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds
about 6 hours ago
UnitedHealth Group’s colossal size has helped the conglomerate turn the way patients...
Judge orders HHS to restore funding for children’s health programs as lawsuit continues
about 8 hours ago
NEW YORK — A federal judge has ordered the Trump administration to...
STAT+: Medicaid funding floodgates, and JPM26 is here
about 9 hours ago
This is the online version of STAT’s weekly email newsletter Health Care...
State of the union’s cardiovascular health: Gains, but not for everyone
about 10 hours ago
Where do we stand on cardiovascular health in America In the first...
STAT+: Pharmalittle: We’re reading about a ‘sledgehammer’ to innovation, longevity medicine, and more
about 10 hours ago
Good morning, everyone, and welcome to another working week. We hope the...
STAT+: Insmed basks in the success of its lung disease drug — and prepares for what’s next
about 11 hours ago
SAN FRANCISCO — When I met Insmed CEO Will Lewis in Boston...
Testosterone in the dietary guidelines?
about 12 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Investor behind Moderna says U.S. policy is ‘taking a sledgehammer to our miracle machine’
about 15 hours ago
SAN FRANCISCO — Noubar Afeyan, one of biotech’s top investors, warned in...